Central venous catheter is a thin, flexible tube (catheter) that is
placed into the large vein above the heart, usually through a vein in
the neck, chest, or arm. It’s also called the central venous line
or central line. Central venous catheters are used to administer
chemotherapy drugs, intravenous (IV) fluids, antibiotics, blood and
platelet transfusions, parenteral nutrition, etc. The peripherally
inserted catheter is the commonly used central venous catheter due to
several advantages such as easy to insert and remove, easy to repair.
Central venous catheters need special care. They may require regular
cleaning or dressing employing sterile techniques. Central venous
access is a commonly performed procedure with about 8% of
hospitalized patients needing central venous access during the course
of their hospital stay. More than five million central venous
catheters are inserted in the U.S. each year.
Rising adoption and increasing demand for antimicrobial-coated
catheters, rising number of chronic diseases such as cancer,
end-stage renal disease and others, increasing geriatric population,
and rising usage of tip location devices are anticipatead to drive
the global central venous catheter market. Other factors such as
favorable insurance and reimbursement policies, technological
innovation, and early adoption of diagnostic procedures are likely to
fuel the overall central venous catheter market. According to the
U.S. Department of Health and Human Services, national expenditures
for cancer treatment in the U.S. was nearly US$ 125 billion in 2010
and is estimated to reach US$ 156 billion by 2020. On the other hand,
the risks associated with catheters and pricing pressure are
projected to hinder the expansion of the global central venous
catheter market.
The central venous catheter market has been segmented based on
product type, route of insertion, application, end-user and region.
In terms of product type, the market can be segmented into
peripherally-inserted central catheter (PICC), non-tunneled
catheters, tunneled catheter, and implanted port. In terms of route
of insertion, the central venous catheter market can be segmented
into intravenous and subcutaneous. Based on application, the central
venous catheter market can be segmented into medication
administration, administration of fluid and nutrition, transfusion of
blood products, and diagnostic testing. In terms of end-user, the
market can be segmented into hospitals, clinics, ambulatory surgery
centers, and diagnostic centers.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31340
In terms of region, the central venous catheter market has been
segmented into North America, Latin America, Europe, Asia Pacific,
and Middle East & Africa.
North America dominates the global central venous catheter market due
to technological advancement, rising prevalence of cancer,
cardiovascular and end stage renal diseases, and rising geriatric
population. According to the American Cancer Society, about 1,688,780
new cancer cases are expected to be diagnosed in 2017 in the U.S.
Europe is the second largest market for central venous catheter due
to increasing number of patients undergoing dialysis and transfusion
of blood products, and rising lifestyle diseases. The central venous
catheter market in Asia Pacific is estimated to expand at higher rate
due to the large population base, high target patient pool,
increasing government initiatives to provide better healthcare
facilities, rising disposable income, and per capita health care
expenditure. According to the World Health Organization, Singapore
ranks sixth, globally, for its advanced healthcare system and offers
the fourth best healthcare infrastructure in the world. Demand for
advanced medical technologies is anticipated to strengthen its
reputation as a healthcare hub in the region.
Major players operating in the global central venous catheter market
include B. Braun Melsungen AG, Becton, Dickinson and Company, C. R.
Bard, Cook Medical, Teleflex Incorporated, Siemens Healthineers, and
AngioDynamics, Inc.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=31340<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment